Juno Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Juno Therapeutics

Access the complete profile.

Juno Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	400 Dexter Avenue North Suite 1200 Seattle, WA 98109

Note: Revenues for privately held companies are statistical evaluations.


Juno Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Juno Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Juno Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Juno Therapeutics Annual Revenue and Growth Rate

Juno Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Juno Therapeutics's revenues are gauged from an analysis of company filings.

Juno Therapeutics's Income Statement (based on Industry Averages)

Juno Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Juno Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
October 5, 2017	1	100%	$31 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Juno Therapeutics is developing and marketing. Juno Therapeutics doesn't have any recent trademark applications, indicating Juno Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
KONFIRI Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use	05/13/2020
BREYANZI Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy	08/07/2019
LISO-CEL Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use	12/08/2017

See all trademarks and details in the Full Report.

Market Share of Juno Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Juno Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Juno Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FRED HUTCHINSON CANCER CENTER	Seattle, WA	100
ADAPTIVE BIOTECHNOLOGIES	Seattle, WA	14
ALLEN INSTITUTE	Seattle, WA	13
JUNO THERAPEUTICS	Seattle, WA	13
SANA BIOTECHNOLOGY	Seattle, WA	9
ULTRA SAFE NUCLEAR	Seattle, WA	5

Future Competition: Juno Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Juno Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)